Literature DB >> 6225116

Three distinct stages of B-cell defects in common varied immunodeficiency.

O Saiki, P Ralph, C Cunningham-Rundles, R A Good.   

Abstract

B-lymphocyte function of 15 patients with primary common varied immunodeficiency or related disease were examined. All patients had low serum levels of IgM, IgG, and IgA, but 12 of 15 patients had nearly normal numbers of peripheral blood B lymphocytes. Mononuclear cells and B cells from peripheral blood were assayed for B-cell mitogenic responses to anti-Ig mu chain antibodies or to Staphylococcus aureus strain Cowan I (referred to as Cowan I), and for differentiation to Ig-secreting cells of IgM, IgG, and IgA classes in the presence of Cowan I and pokeweed mitogen or T-cell factor. The patients all showed profound B-cell defects in one or more of the assays and could be divided into three approximately equal groups based on their responses. The first group showed normal proliferation in response to the two B-cell mitogens and near normal numbers of IgM-secreting cells but no IgG- or IgA-secreting cells. B cells in the second group showed proliferative responses to Cowan I or anti-mu, but no differentiation to Ig-secreting cells. The third group had no B-cell proliferative responses or differentiation in our assays. In several patients from each group, (i) helper T cells were functional in Ig-secreting-cell responses with purified normal B cells, (ii) patient T cells did not significantly suppress formation of Ig-secreting cells by normal cells in coculture, and (iii) removal of T cells with addition of T-cell-replacing factor, or partial removal of monocytes, did not alleviate any of the defects. These studies show that primary B-cell defects in common varied immunodeficiency occur at several levels, probably representing blocks at different stages of differentiation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6225116      PMCID: PMC347041          DOI: 10.1073/pnas.79.19.6008

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect.

Authors:  E G de la Concha; G Oldham; A D Webster; G L Asherson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

2.  Heterogeneity of "acquired" or common variable agammaglobulinemia.

Authors:  R S Geha; E Schneeberger; E Merler; F S Rosen
Journal:  N Engl J Med       Date:  1974-07-04       Impact factor: 91.245

3.  Modulatory effects on immunoglobulin synthesis and secretion by lymphocytes from immunodeficient patients.

Authors:  S A Schwartz; Y S Choi; L Shou; R A Good
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

4.  Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias.

Authors:  F P Siegal; M Siegal; R A Good
Journal:  N Engl J Med       Date:  1978-07-27       Impact factor: 91.245

5.  Disorders of suppressor immunoregulatory cells in the pathogenesis of immunodeficiency and autoimmunity.

Authors:  T A Waldmann; R M Blaese; S Broder; R S Krakauer
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

6.  Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.

Authors:  T Kataoka; T Kawakami; N Takahashi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

7.  Lymphocyte stimulation by protein A of Staphylococcus aureus.

Authors:  A Forsgren; A Svedjelund; H Wigzell
Journal:  Eur J Immunol       Date:  1976-03       Impact factor: 5.532

8.  Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture.

Authors:  P Ralph; I Nakoinz
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

Review 9.  Human lymphocyte differentiation markers and their application to immune deficiency and lymphoproliferative diseases.

Authors:  F P Siegal; R A Good
Journal:  Clin Haematol       Date:  1977-06

10.  Differentiation capacity of cultured B lymphocytes from immunodeficient patients.

Authors:  L Y Wu; A R Lawton; M D Cooper
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

View more
  48 in total

1.  Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation.

Authors:  M Di Renzo; Z Zhou; I George; K Becker; C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 2.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  IgH sequences in common variable immune deficiency reveal altered B cell development and selection.

Authors:  Krishna M Roskin; Noa Simchoni; Yi Liu; Ji-Yeun Lee; Katie Seo; Ramona A Hoh; Tho Pham; Joon H Park; David Furman; Cornelia L Dekker; Mark M Davis; Judith A James; Kari C Nadeau; Charlotte Cunningham-Rundles; Scott D Boyd
Journal:  Sci Transl Med       Date:  2015-08-26       Impact factor: 17.956

4.  Large cell lymphoma presenting as a flare of colitis in a patient with common variable immune deficiency.

Authors:  Megan Dunnigan; Harris Yfantis; Aaron P Rapoport; Keya Hosseinzadeh; Christopher D Gocke; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

5.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

6.  Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity.

Authors:  D U Braig; A A Schäffer; E Glocker; U Salzer; K Warnatz; H H Peter; B Grimbacher
Journal:  Hum Genet       Date:  2003-02-06       Impact factor: 4.132

Review 7.  Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient.

Authors:  S Doi; O Saiki; T Hara; T Sugita; K Ha-Kawa; T Tanaka; H Hara; S Negoro; H Yabuuchi; S Kishimoto
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

8.  Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors.

Authors:  L Mayer; S M Fu; C Cunningham-Rundles; H G Kunkel
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency.

Authors:  M B Fischer; H M Wolf; H Eggenbauer; V Thon; E Vogel; J Lokaj; J Litzman; J W Mannhalter; M M Eibl
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  Intestinal B cell defects in common variable immunodeficiency.

Authors:  E W Herbst; M Armbruster; J A Rump; H P Buscher; H H Peter
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.